{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T11:10:52Z","timestamp":1790680252228,"version":"4.1.0"},"reference-count":80,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,10,29]],"date-time":"2018-10-29T00:00:00Z","timestamp":1540771200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Microbiol."],"DOI":"10.3389\/fmicb.2018.02587","type":"journal-article","created":{"date-parts":[[2018,10,29]],"date-time":"2018-10-29T00:56:36Z","timestamp":1540774596000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":207,"title":["Drug Resistance in Toxoplasma gondii"],"prefix":"10.3389","volume":"9","author":[{"given":"Mahbobeh","family":"Montazeri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saeed","family":"Mehrzadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehdi","family":"Sharif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahabeddin","family":"Sarvi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asal","family":"Tanzifi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sargis A.","family":"Aghayan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad","family":"Daryani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2018,10,29]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"273","DOI":"10.2147\/DDDT.S60973","article-title":"Drugs in development for toxoplasmosis: advances, challenges, and current status","volume":"11","author":"Alday","year":"2017","journal-title":"Drug Des. Dev. Ther."},{"key":"B2","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1051\/parasite\/2005122171","article-title":"Efficacy of atovaquone and sulfadiazine in the treatment of mice infected with Toxoplasma gondii strains isolated in Brazil","volume":"12","author":"Alves","year":"2005","journal-title":"Parasite"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1086\/340577","article-title":"The molecular basis of sulfonamide resistance in Toxoplasma gondii and implications for the clinical management of toxoplasmosis","volume":"185","author":"Aspinall","year":"2002","journal-title":"J. Infect. Dis."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1086\/517411","article-title":"Selection and characterization of Toxoplasma gondii mutants resistant to artemisinin","volume":"177","author":"Berens","year":"1998","journal-title":"J. Infect. Dis."},{"key":"B5","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S0248-8663(98)80100-8","article-title":"Epidemiologic characteristics of cerebral toxoplasmosis in 399 HIV-infected patients followed between 1983 and 1994","volume":"19","author":"Bossi","year":"1998","journal-title":"Rev. Med. Interne"},{"key":"B6","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1073\/pnas.1416611112","article-title":"Antimalarial 4 (1H)-pyridones bind to the Qi site of cytochrome bc1","volume":"112","author":"Capper","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1086\/339551","article-title":"Randomized phase II trial of atovaquone with pyrimethamine or sulfadiazine for treatment of toxoplasmic encephalitis in patients with acquired immunodeficiency syndrome: ACTG 237\/ANRS 039 study","volume":"34","author":"Chirgwin","year":"2002","journal-title":"Clin. Infect. Dis."},{"key":"B8","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1146\/annurev.physiol.66.032102.150251","article-title":"The cytochrome bc1 complex: function in the context of structure","volume":"66","author":"Crofts","year":"2004","journal-title":"Annu. Rev. Physiol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"57","DOI":"10.4269\/ajtmh.15-0007","article-title":"Antimalarial drug resistance: literature review and activities and findings of the ICEMR network","volume":"93","author":"Cui","year":"2015","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"B10","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1016\/j.biopha.2017.11.007","article-title":"The potential use of melatonin to treat protozoan parasitic infections: a review","volume":"97","author":"Daryani","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"B11","doi-asserted-by":"publisher","first-page":"15936","DOI":"10.1073\/pnas.1208069109","article-title":"Endochin-like quinolones are highly efficacious against acute and latent experimental toxoplasmosis","volume":"109","author":"Doggett","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B12","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1051\/parasite\/2013020","article-title":"Sulfadiazine resistance in Toxoplasma gondii: no involvement of overexpression or polymorphisms in genes of therapeutic targets and ABC transporters","volume":"20","author":"Doliwa","year":"","journal-title":"Parasite"},{"key":"B13","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.exppara.2012.11.019","article-title":"Induction of sulfadiazine resistance in vitro in Toxoplasma gondii","volume":"133","author":"Doliwa","year":"","journal-title":"Exp. Parasitol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.ijpddr.2012.12.002","article-title":"Identification of differentially expressed proteins in sulfadiazine resistant and sensitive strains of Toxoplasma gondii using difference-gel electrophoresis (DIGE)","volume":"3","author":"Doliwa","year":"","journal-title":"Int. J. Parasitol. Drugs Drug Resist."},{"key":"B15","doi-asserted-by":"publisher","first-page":"11703","DOI":"10.1073\/pnas.90.24.11703","article-title":"Stable molecular transformation of Toxoplasma gondii: a selectable dihydrofolate reductase-thymidylate synthase marker based on drug-resistance mutations in malaria","volume":"90","author":"Donald","year":"1993","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"B16","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/S0166-6851(98)00154-6","article-title":"Stable transformation of Toxoplasma gondii based on a pyrimethamine resistant trifunctional dihydrofolate reductase-cytosine deaminase-thymidylate synthase gene that confers sensitivity to 5-fluorocytosine","volume":"98","author":"Fox","year":"1999","journal-title":"Mol. Biochem. Parasitol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1111\/tid.12532","article-title":"Failure of primary atovaquone prophylaxis for prevention of toxoplasmosis in hematopoietic cell transplant recipients","volume":"18","author":"Gajurel","year":"2016","journal-title":"Transpl. Infect. Dis."},{"key":"B18","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1111\/j.1365-2958.2009.06655.x","article-title":"Disruption of a mitochondrial MutS DNA repair enzyme homologue confers drug resistance in the parasite Toxoplasma gondii","volume":"72","author":"Garrison","year":"2009","journal-title":"Mol. Microbiol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/S0002-9394(14)73976-5","article-title":"An unusually high prevalence of ocular toxoplasmosis in southern Brazil","volume":"114","author":"Glasner","year":"1992","journal-title":"Am. J. Ophthalmol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.molbiopara.2013.05.008","article-title":"Identification of dihydroorotate dehydrogenase as a relevant drug target for 1-Hydroxyquinolones in Toxoplasma gondii","volume":"190","author":"Hegewald","year":"2013","journal-title":"Mol. Biochem. Parasitol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1093\/infdis\/172.6.1561","article-title":"Toxoplasma gondii comprises three clonal lineages: correlation of parasite genotype with human disease","volume":"172","author":"Howe","year":"1995","journal-title":"J. Infect. Dis"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1128\/AAC.40.6.1360","article-title":"Pyrimethamine pharmacokinetics in human immunodeficiency virus-positive patients seropositive for Toxoplasma gondii","volume":"40","author":"Jacobson","year":"1996","journal-title":"Antimicrob. Agents Chemother."},{"key":"B23","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.molbiopara.2005.12.002","article-title":"Molecular basis of Toxoplasma gondii atovaquone resistance modeled in Saccharomyces cerevisiae","volume":"146","author":"Kessl","year":"2006","journal-title":"Mol. Biochem. Parasitol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/0140-6736(92)92172-C","article-title":"Efficacy of atovaquone in treatment of toxoplasmosis in patients with AIDS","volume":"340","author":"Kovacs","year":"1992","journal-title":"Lancet"},{"key":"B25","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1017\/S0031182011001776","article-title":"The adaptive potential of a survival artist: characterization of the in vitro interactions of Toxoplasma gondii tachyzoites with di-cationic compounds in human fibroblast cell cultures","volume":"139","author":"Kropf","year":"2012","journal-title":"Parasitology"},{"key":"B26","doi-asserted-by":"publisher","first-page":"e42107","DOI":"10.1371\/journal.pone.0042107","article-title":"Analysis of monensin sensitivity in Toxoplasma gondii reveals autophagy as a mechanism for drug induced death","volume":"7","author":"Lavine","year":"2012","journal-title":"PLoS ONE"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1084\/jem.20151519","article-title":"Radical cure of experimental babesiosis in immunodeficient mice using a combination of an endochin-like quinolone and atovaquone","volume":"27","author":"Lawres","year":"2016","journal-title":"J. Exp. Med."},{"key":"B28","doi-asserted-by":"crossref","first-page":"459","DOI":"10.2307\/3283832","article-title":"Ultrastructural effects of diclazuril against Toxoplasma gondii and investigation of a diclazuril-resistant mutant","volume":"81","author":"Lindsay","year":"1995","journal-title":"J. Parasitol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1093\/clinids\/15.2.211","article-title":"Toxoplasmic encephalitis in AIDS","volume":"15","author":"Luft","year":"1992","journal-title":"Clin. Infect. Dis"},{"key":"B30","doi-asserted-by":"publisher","first-page":"4711","DOI":"10.1091\/mbc.e07-04-0379","article-title":"Mutations in \u03b1-tubulin confer dinitroaniline resistance at a cost to microtubule function","volume":"18","author":"Ma","year":"2007","journal-title":"Mol. Biol. Cell"},{"key":"B31","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1534\/genetics.108.092494","article-title":"Secondary mutations correct fitness defects in Toxoplasma gondii with dinitroaniline resistance mutations","volume":"180","author":"Ma","year":"2008","journal-title":"Genetics"},{"key":"B32","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1054\/drup.2001.0184","article-title":"Resistance as a tool in the study of old and new drug targets in Toxoplasma","volume":"4","author":"McFadden","year":"2001","journal-title":"Drug Resist. Updates"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1128\/AAC.41.9.1849","article-title":"Use of Toxoplasma gondii expressing -galactosidase for colorimetric assessment of drug activity in vitro","volume":"41","author":"McFadden","year":"1997","journal-title":"Antimicrob. Agents Chemother."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0166-6851(00)00184-5","article-title":"Characterization of cytochrome b from Toxoplasma gondii and Q o domain mutations as a mechanism of atovaquone-resistance","volume":"108","author":"McFadden","year":"2000","journal-title":"Mol. Biochem. Parasitol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1086\/501360","article-title":"Outcome of treatment for congenital toxoplasmosis, 1981\u20132004: the national collaborative Chicago-based, congenital toxoplasmosis study","volume":"42","author":"McLeod","year":"2006","journal-title":"Clin. Infect. Dis"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1128\/AAC.01203-07","article-title":"In vitro susceptibility of various genotypic strains of Toxoplasma gondii to pyrimethamine, sulfadiazine, and atovaquone","volume":"52","author":"Meneceur","year":"2008","journal-title":"Antimicrob. Agents.Chemother."},{"key":"B37","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1586\/eri.12.58","article-title":"Toxoplasmosis in the fetus and newborn: an update on prevalence, diagnosis and treatment","volume":"10","author":"Moncada","year":"2012","journal-title":"Expert Rev. Anti Infect. Ther"},{"key":"B38","doi-asserted-by":"publisher","first-page":"e22572","DOI":"10.5812\/jjm.22572","article-title":"Effect of propranolol alone and in combination with pyrimethamine on acute murine toxoplasmosis","volume":"8","author":"Montazeri","year":"2015","journal-title":"Jundishapur J.Microbiol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"3045","DOI":"10.1007\/s00436-018-6027-z","article-title":"Activities of anti-Toxoplasma drugs and compounds against tissue cysts in the last three decades (1987 to 2017), a systematic review","volume":"117","author":"Montazeri","year":"2018","journal-title":"Parasitol. Res"},{"key":"B40","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s41182-017-0079-0","article-title":"Survey on synergism effect of ketotifen in combination with pyrimethamine in treatment of acute murine toxoplasmosis","volume":"45","author":"Montazeri","year":"","journal-title":"Trop. Med. Int"},{"key":"B41","doi-asserted-by":"publisher","first-page":"25","DOI":"10.3389\/fmicb.2017.00025","article-title":"A systematic review of in vitro and in vivo activities of anti-toxoplasma drugs and compounds (2006\u20132016)","volume":"8","author":"Montazeri","year":"","journal-title":"Front Microbiol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.1016\/S0140-6736(04)16412-X","article-title":"Toxoplasmosis","volume":"363","author":"Montoya","year":"2004","journal-title":"Lancet"},{"key":"B43","doi-asserted-by":"publisher","first-page":"1960","DOI":"10.1091\/mbc.e03-07-0530","article-title":"Dinitroanilines bind \u03b1-tubulin to disrupt microtubules","volume":"15","author":"Morrissette","year":"2004","journal-title":"Mol. Biol. Cell"},{"key":"B44","doi-asserted-by":"publisher","first-page":"3816","DOI":"10.1128\/AAC.00582-07","article-title":"Artemisinin-resistant mutants of Toxoplasma gondii have altered calcium homeostasis","volume":"51","author":"Nagamune","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"key":"B45","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1084\/jem.20110039","article-title":"Apicoplast isoprenoid precursor synthesis and the molecular basis of fosmidomycin resistance in Toxoplasma gondii","volume":"208","author":"Nair","year":"2011","journal-title":"J. Exp. Med"},{"key":"B46","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1590\/0074-02760150459","article-title":"Pathogenicity and phenotypic sulfadiazine resistance of Toxoplasma gondii isolates obtained from livestock in northeastern Brazil","volume":"111","author":"Oliveira","year":"2016","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"B47","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1046\/j.1365-3156.2001.00777.x","article-title":"Biochemical and molecular mechanisms of drug resistance in parasites","volume":"6","author":"Ouellette","year":"2001","journal-title":"Trop. Med. Int. Health"},{"key":"B48","doi-asserted-by":"publisher","first-page":"921","DOI":"10.4236\/ijcm.2014.515124","article-title":"Novel synergistic protective efficacy of atovaquone and diclazuril on fetal-maternal toxoplasmosis","volume":"5","author":"Oz","year":"2014","journal-title":"Int. J. Clin. Med"},{"key":"B49","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1016\/j.ijpara.2009.04.003","article-title":"Toxoplasmosis snapshots: global status of Toxoplasma gondii seroprevalence and implications for pregnancy and congenital toxoplasmosis","volume":"39","author":"Pappas","year":"2009","journal-title":"Int. J. Parasitol."},{"key":"B50","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1128\/AAC.38.1.31","article-title":"Comparison of mutants of Toxoplasma gondii selected for resistance to azithromycin, spiramycin, or clindamycin","volume":"38","author":"Pfefferkorn","year":"","journal-title":"Antimicrob. Agents Chemother."},{"key":"B51","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1006\/expr.1994.1099","article-title":"Toxoplasma gondii: characterization of a mutant resistant to 6-thioxanthine","volume":"79","author":"Pfefferkorn","year":"","journal-title":"Exp Parasitol"},{"key":"B52","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/0014-4894(92)90149-5","article-title":"Toxoplasma gondii: characterization of a mutant resistant to sulfonamides","volume":"74","author":"Pfefferkorn","year":"","journal-title":"Exp Parasitol"},{"key":"B53","doi-asserted-by":"crossref","first-page":"559","DOI":"10.2307\/3283383","article-title":"Mutants of Toxoplasma gondii resistant to atovaquone (566C80) or decoquinate","volume":"79","author":"Pfefferkorn","year":"1993","journal-title":"J. Parasitol"},{"key":"B54","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/0014-4894(88)90133-6","article-title":"Toxoplasma gondii: in vivo and in vitro studies of a mutant resistant to arprinocid-N-oxide","volume":"65","author":"Pfefferkorn","year":"1988","journal-title":"Exp. Parasitol"},{"key":"B55","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/0014-4894(83)90015-2","article-title":"Toxoplasma gondii: genetic crosses reveal phenotypic suppression of hydroxyurea resistance by fluorodeoxyuridine resistance","volume":"55","author":"Pfefferkorn","year":"1983","journal-title":"Exp. Parasitol."},{"key":"B56","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1128\/AAC.36.5.1091","article-title":"Parasiticidal effect of clindamycin on Toxoplasma gondii grown in cultured cells and selection of a drug-resistant mutant","volume":"36","author":"Pfefferkorn","year":"","journal-title":"Antimicrob. Agents Chemother."},{"key":"B57","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/0014-4894(77)90060-1","article-title":"Toxoplasma gondii: characterization of a mutant resistant to 5-fluorodeoxyuridine","volume":"42","author":"Pfefferkorn","year":"1977","journal-title":"Exp. Parasitol"},{"key":"B58","doi-asserted-by":"publisher","first-page":"486","DOI":"10.2307\/3279789","article-title":"The biochemical basis for resistance to adenine arabinoside in a mutant of Toxoplasma gondii","volume":"64","author":"Pfefferkorn","year":"1978","journal-title":"J. Parasitol"},{"key":"B59","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/0014-4894(80)90034-X","article-title":"Toxoplasma gondii: genetic recombination between drug resistant mutants","volume":"50","author":"Pfefferkorn","year":"1980","journal-title":"Exp. Parasitol."},{"key":"B60","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1056\/NEJM199212033272306","article-title":"Toxoplasmosis of the central nervous system in the acquired immunodeficiency syndrome","volume":"327","author":"Porter","year":"1992","journal-title":"N. Engl. J. Med"},{"key":"B61","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1179\/2047773213Y.0000000094","article-title":"Antibiotics for human toxoplasmosis: a systematic review of randomized trials","volume":"107","author":"Rajapakse","year":"2013","journal-title":"Pathog. Glob. Health"},{"key":"B62","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1128\/AAC.45.4.1271-1277.2001","article-title":"In Vitro generation of novel pyrimethamine resistance mutations in the Toxoplasma gondii dihydrofolate reductase","volume":"45","author":"Reynolds","year":"2001","journal-title":"Antimicrob. Agents Chemother."},{"key":"B63","doi-asserted-by":"publisher","first-page":"3461","DOI":"10.1074\/jbc.273.6.3461","article-title":"A biochemical and genetic model for parasite resistance to antifolates Toxoplasma gondii provides insights into pyrimethamine and cycloguanil resistance in Plasmodium falciparum","volume":"273","author":"Reynolds","year":"1998","journal-title":"J. Biol. Chem"},{"key":"B64","doi-asserted-by":"publisher","first-page":"2358","DOI":"10.1128\/AAC.37.11.2358","article-title":"Toxoplasma gondii: susceptibility and development of resistance to anticoccidial drugs in vitro","volume":"37","author":"Ricketts","year":"1993","journal-title":"Antimicrob. Agents Chemother."},{"key":"B65","first-page":"531","article-title":"Development of sulphonamide resistance in Toxoplasma gondii","volume":"79","author":"Sander","year":"1971","journal-title":"APMIS"},{"key":"B66","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1645\/13-451.1","article-title":"A thiazole derivative of artemisinin moderately reduces Toxoplasma gondii cyst burden in infected mice","volume":"100","author":"Schultz","year":"2014","journal-title":"J. Parasitol"},{"key":"B67","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1016\/j.tmaid.2014.05.007","article-title":"Toxoplasmosis as a travel risk","volume":"12","author":"Sep\u00falveda-Arias","year":"2014","journal-title":"Travel Med. Infect. Dis."},{"key":"B68","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1017\/S0031182013001844","article-title":"Geographical patterns of Toxoplasma gondii genetic diversity revealed by multilocus PCR- RFLP genotyping","volume":"141","author":"Shwab","year":"2014","journal-title":"Parasitology"},{"key":"B69","doi-asserted-by":"publisher","first-page":"e0170689","DOI":"10.1371\/journal.pone.0170689","article-title":"Genetic polymorphisms and phenotypic profiles of sulfadiazine-resistant and sensitive Toxoplasma gondii isolates obtained from newborns with congenital toxoplasmosis in minas gerais, Brazil","volume":"12","author":"Silva","year":"2017","journal-title":"PloS ONE"},{"key":"B70","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1007\/978-1-60327-595-8_31","article-title":"Drug resistance in Toxoplasma gondii","volume-title":"Antimicrobial Drug Resistance. Infectious Disease","author":"Sims","year":"2009"},{"key":"B71","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1128\/EC.00351-09","article-title":"Use of the kinase inhibitor analog 1NM-PP1 reveals a role for Toxoplasma gondii CDPK1 in the invasion step","volume":"9","author":"Sugi","year":"2010","journal-title":"Eukaryotic Cell"},{"key":"B72","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ijpddr.2014.12.001","article-title":"A single mutation in the gatekeeper residue in TgMAPKL-1 restores the inhibitory effect of a bumped kinase inhibitor on the cell cycle","volume":"5","author":"Sugi","year":"2015","journal-title":"Int. J. Parasitol. Drugs Drug Resist."},{"key":"B73","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.ijpddr.2013.04.001","article-title":"Identification of mutations in TgMAPK1 of Toxoplasma gondii conferring resistance to 1NM-PP1","volume":"3","author":"Sugi","year":"2013","journal-title":"Int. J. Parasitol. Drugs Drug Resist"},{"key":"B74","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1016\/S0020-7519(00)00124-7","article-title":"Toxoplasma gondii: from animals to humans","volume":"30","author":"Tenter","year":"2000","journal-title":"Int. J. Parasitol."},{"key":"B75","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1016\/0020-7519(95)00066-B","article-title":"Interconnection between organellar functions, development and drug resistance in the protozoan parasite, Toxoplasma gondii","volume":"25","author":"Tomavo","year":"1995","journal-title":"Int. J. Parasitol."},{"key":"B76","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1089\/fpd.2005.2.221","article-title":"Foodborne infections in France","volume":"2","author":"Vaillant","year":"2005","journal-title":"Foodborne Pathog. Dis"},{"key":"B77","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.exppara.2017.01.001","article-title":"Extended-spectrum antiprotozoal bumped kinase inhibitors: a review","volume":"180","author":"Van Voorhis","year":"2017","journal-title":"Exp. Parasitol."},{"key":"B78","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1080\/00365549850160963","article-title":"Pyrimethamine-sulfadoxine treatment of congenital toxoplasmosis: follow-up of 78 cases between 1980 and 1997","volume":"30","author":"Villena","year":"1998","journal-title":"Scand. J. Infect. Dis"},{"key":"B79","doi-asserted-by":"publisher","first-page":"389","DOI":"10.3389\/fmicb.2017.00389","article-title":"Toxoplasma gondii infection in immunocompromised patients: a systematic review and meta-analysis","volume":"8","author":"Wang","year":"2017","journal-title":"Front. Microbiol."},{"key":"B80","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.exppara.2007.10.016","article-title":"Antimalarial quinolones: synthesis, potency, and mechanistic studies","volume":"118","author":"Winter","year":"2008","journal-title":"Exp. Parasitol."}],"container-title":["Frontiers in Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fmicb.2018.02587\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,29]],"date-time":"2018-10-29T00:56:39Z","timestamp":1540774599000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fmicb.2018.02587\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,29]]},"references-count":80,"alternative-id":["10.3389\/fmicb.2018.02587"],"URL":"https:\/\/doi.org\/10.3389\/fmicb.2018.02587","relation":{},"ISSN":["1664-302X"],"issn-type":[{"value":"1664-302X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,29]]},"article-number":"2587"}}